Chinook Therapeutics Stock Z Score
KDNYDelisted Stock | USD 40.39 0.00 0.00% |
Chinook |
Chinook Therapeutics Company Z Score Analysis
Chinook Therapeutics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Chinook Therapeutics Z Score | 39.94 |
Most of Chinook Therapeutics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chinook Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Chinook Therapeutics has a Z Score of 39.94. This is much higher than that of the Biotechnology sector and notably higher than that of the Health Care industry. The z score for all United States stocks is notably lower than that of the firm.
Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
All Next | Launch Module |
Chinook Fundamentals
Return On Equity | -0.57 | |||
Return On Asset | -0.27 | |||
Operating Margin | (39.98) % | |||
Current Valuation | 2.64 B | |||
Shares Outstanding | 67.05 M | |||
Shares Owned By Insiders | 2.19 % | |||
Shares Owned By Institutions | 96.71 % | |||
Number Of Shares Shorted | 2.88 M | |||
Price To Book | 3.06 X | |||
Price To Sales | 27.90 X | |||
Revenue | 6.13 M | |||
Gross Profit | (135.08 M) | |||
EBITDA | (164.2 M) | |||
Net Income | (187.87 M) | |||
Cash And Equivalents | 362.61 M | |||
Cash Per Share | 5.76 X | |||
Total Debt | 39.44 M | |||
Debt To Equity | 0.08 % | |||
Current Ratio | 12.60 X | |||
Book Value Per Share | 5.32 X | |||
Cash Flow From Operations | (117.48 M) | |||
Short Ratio | 3.43 X | |||
Earnings Per Share | (3.24) X | |||
Price To Earnings To Growth | (0.99) X | |||
Target Price | 40.3 | |||
Number Of Employees | 214 | |||
Beta | 0.67 | |||
Market Capitalization | 2.71 B | |||
Total Asset | 574.08 M | |||
Retained Earnings | (419.63 M) | |||
Working Capital | 334.76 M | |||
Z Score | 39.94 | |||
Net Asset | 574.08 M |
About Chinook Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chinook Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chinook Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chinook Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in Chinook Stock
If you are still planning to invest in Chinook Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chinook Therapeutics' history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |